Iniciar sesión Regístrese gratis

Adma Biologics Inc Ingresos Y/Y

¿Qué es el Ingresos Y/Y de Adma Biologics Inc?

El Ingresos Y/Y de Adma Biologics Inc es 58.69%

¿Cuál es la definición de Ingresos Y/Y?

El crecimiento anual de los ingresos de los últimos 3 años es el crecimiento de los ingresos de un año a otro promediado en los últimos 3 años.

The yearly revenue growth rate is calculated as the percentage change in revenue over the trailing twelve months. For this specific metric, the calculation takes into account a series of the last eight quarterly revenues. The revenue growth is useful for determining the success of the company expanding its main business. Revenue growth of 5% to 10% is usually considered good for large-cap companies. For other companies, a sales growth of over 10% is more desirable.

Ingresos Y/Y de compañías en Sector Health Care en NASDAQ en comparadas con Adma Biologics Inc

¿Qué hace Adma Biologics Inc?

adma is a late-stage biopharmaceutical company that develops, manufactures and intends to commercialize specialty plasma-based biologics for the treatment and prevention of primary immune deficiency disease (pidd) and certain infectious diseases. adma's mission is to develop and commercialize plasma-derived, human immune globulins targeted to niche patient populations for the treatment and prevention of certain infectious diseases. the target patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disease, or who may be immune-compromised for medical reasons. adma’s lead product candidate, ri-002, has completed a phase iii clinical trial in patients with pidd and has met the primary endpoint. a bla for ri-002 was accepted by the fda on september 18, 2015. the company has received u.s. patent 9,107,906. for more information, please visit the company's website at www.admabiologics.com.

Empresas con ingresos y/y similar a Adma Biologics Inc